Literature DB >> 25994002

Use of antibiotics in paediatric primary care settings in Serbia.

Bojana Bozic1, Milica Bajcetic2.   

Abstract

OBJECTIVE: The aim of the study was to compare the quality of antibiotic use among children in primary settings with the internationally developed disease-specific quality indicators and with National Guidelines.
DESIGN: Prescriptions of systemic antibiotics to the paediatric population (<18 years) at the primary level of healthcare for the period between 2011 and 2013 were analysed by using the National Health Insurance Fund's outpatient reimbursement database.
RESULTS: The mean annual number of antibiotic prescriptions was 1.887.615, while the mean annual number of children receiving antibiotics was 728.285. The prescription rate slightly decreased by 10% from 1.516 antibiotic prescriptions per 1000 persons per year in 2011 to 1.365 in 2013. The highest percentage of prescribed antibiotics was observed in the group of children aged 2-23 months. The mean annual prevalence of antibiotic prescriptions was 54%. The percentage of patients prescribed an antibiotic for acute upper respiratory tract infections, acute tonsillitis and acute otitis media (AOM) was above the proposed range (≤ 20), 87% -96%. These three diagnoses represent more than 69% of all indications for prescribing antibiotics. The percentage of patients prescribed a recommended antibiotic was below the proposed range (≥ 80%), 1% -17%, while the adherence rate to National Guidelines was low, 19%-28%. The percentage of patients prescribed quinolones was above the proposed range for AOM (≤ 5%), 7%. There were no significant differences in indicators value at the regional level in Serbia.
CONCLUSIONS: Antibiotic use among children in Serbia is extremely high compared with that in most other European countries. Major problems are frequent use of antibiotics for indications that usually receive no benefit from this treatment and the use of broad-spectrum antibiotics. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Paediatric Practice; Qualitative research

Mesh:

Substances:

Year:  2015        PMID: 25994002     DOI: 10.1136/archdischild-2015-308274

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Variation of antibiotic consumption and its correlated factors in Turkey.

Authors:  Ayfer Sahin; Ahmet Akici; Volkan Aydin; Bahar Melik; Mesil Aksoy; Ali Alkan
Journal:  Eur J Clin Pharmacol       Date:  2017-03-25       Impact factor: 2.953

Review 2.  Learning Lessons from Adverse Drug Reactions in Children.

Authors:  Helen M Sammons; Imti Choonara
Journal:  Children (Basel)       Date:  2016-01-08

3.  Antimicrobial use in paediatric patients in a teaching hospital in Ethiopia.

Authors:  Hafte Kahsay Kebede; Hailay Abrha Gesesew; Tewodros Eyob Woldehaimanot; Kabaye Kumela Goro
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

4.  Antibiotic prescription practices among prescribers for children under five at public health centers III and IV in Mbarara district.

Authors:  Nelson Okello; Joseph Oloro; Catherine Kyakwera; Elias Kumbakumba; Celestino Obua
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

5.  Prescribing Patterns and Variations of Antibiotic Use for Children in Ambulatory Care: A Nationwide Study.

Authors:  Githa Fungie Galistiani; Ria Benkő; Balázs Babarczy; Renáta Papp; Ágnes Hajdu; Éva Henrietta Szabó; Réka Viola; Erika Papfalvi; Ádám Visnyovszki; Mária Matuz
Journal:  Antibiotics (Basel)       Date:  2022-01-31

6.  Cross-sectional study of drug utilisation in a Chinese neonatal unit.

Authors:  Yan Yue; Libin Chen; Imti Choonara; Tao Xiong; Shalini Ojha; Jun Tang; Yan Wang; Linan Zeng; Jing Shi; Hua Wang; Dezhi Mu
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

7.  Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 2017.

Authors:  Niels Adriaenssens; Robin Bruyndonckx; Ann Versporten; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal:  J Antimicrob Chemother       Date:  2021-07-26       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.